安寧緩和醫療修法後對巴拉刈中毒末期病人醫療過程之影響

Influence to Paraguat Intoxication Terminal Patient Care after Hospice Palliative Care Regulation Revision

10.6537/TJHPC.2016.21(1).4

馬瑞菊(Jui-Chu Ma)；鄭婉如(Wan-Ju Cheng)；林佩璇(Pei-Xuan Lin)；李佳欣(Chin-Hsin Li)；涂穎慧(Tu-Yin Hui)；蘇珉一(Min-I Su)

巴拉刈中毒 ； 不予處置維生醫療 ； 緩和醫療 ； 緩和鎮靜 ； 醫療支出 ； Paraguat intoxication ； Withholding of Life Sustaining Treatment ； palliative care ； palliative sedation ； medical expenses

安寧療護雜誌

21卷1期（2016 / 03 / 01）

46 - 60

繁體中文

研究目的：探討2013年安寧緩和醫療修法前、後加護病房巴拉刈中毒病人安寧療護之經驗。材料與方法：採電子病歷回溯性調查設計，以加護病房2009年1月至2015年12月中毒之個案進行分析，並以自擬結構性調查表進行資料收集及統計。結果：收案之68位個案基本資料並無統計上之差異。50位死亡個案中在安寧修法後之病人全數皆簽署DNR(n=22;佔100%)，且有19位(佔86%)死亡前未使用強心藥物，選擇不予處置(Withholding of Life Sustaining Treatment)(插管併呼吸器)的有16位(佔72.73%)。有9人(佔41%)使用緩和鎮靜藥物(Morphine)，加護病房平均住院日由修法前的4.14天(SD=4.49)下降為修法後之2.18天(SD=1.47)，以上皆達統計上顯著差異。住院期間之醫療支出，由修法前的93811.93 台幣降至修法後之63164.82 台幣(下降23%，近30000元之支出)。結論：嚴重巴拉刈中毒病人病情進展快速，短期內即進展到死亡，若能及時提供末期巴拉刈中毒病人(或家屬)緩和醫療之治療方針及維生醫療抉擇之討論，不僅可以避免無效之延命醫療，使病人能安祥有尊嚴的離世，亦可讓家屬在有限的時間裡陪伴病人並做最後的告別。

Objectives: To discuss the experience of hospice care to paraguat intoxication patient in intensive care unit before and after Taiwan hospice palliative care regulation revision in 2013. Method: Adopt the electronic medical record backtracking survey design, analyze the individual case of intoxication in intensive care unit from January of 2009 to December of 2015, and collect and make statistics of data through the self-prepared structural questionnaire. Result: There is no significant difference in basic characteristics among the collected 68 cases. In the 50 death cases, all the patients have accepted DNR(n=22;100%) after the hospice regulation revision, and 19 cases (86%) did not use the inotropic agent before died, and 16 cases (72.73%) selected the withholding of life sustaining treatment(such as intubation with ventilator) for life sustaining treatment. 9 cases (41%) used the palliative sedation (Morphine) medicine. The average length of stay in intensive care unit decreases from 4.14 days before the regulation revision to 2.18 days after the regulation revision, and the data above all realize the statistical significant difference. The medical expenses during the hospital stay decreases from NT$ 93,811.93 before the regulation revision to NT$ 63,164.82 after the regulation revision (decreased 23%, nearly NT$ 30,000). Conclusion: The state of severe paraguat intoxication patient develops rapidly, to the death in the short term. If it could timely provide the palliative care treatment policy and selection discussion of Life Sustaining Treatment to the paraguat intoxication terminal patient and family members, it could not only avoid the futile life extension treatment, to allow the patient passing away in peace and with dignity, but also let the family members accompany the patient and make the last farewell within the limited time.

1. 馬瑞菊,鄭婉如,李佳欣,林佩璇,蘇珉一(2015)。加護病房生命末期病人撤除氣管內管之經驗分析。安寧療護雜誌，20(2)，120-132。
   連結：
2. 陳雪姝,謝秋萍,李幸諭,蔡瓊玉,李哲瑋(2015)。安寧療護使用天數對末期病人醫療資源耗用之影響。台灣公共衛生雜誌，34(4)，413-423。
   連結：
3. 楊秀儀(2013)。論病人之拒絕維生醫療權法律理論與臨床實踐。生命教育研究期刊，5(1)，1-23。
   連結：
4. 趙可式(2015)。安寧療護是普世價值且為護理的本質。護理雜誌，62(2)，5-12。
   連結：
5. 全國法規資料庫。安寧緩和醫療條例。2016 年 1 月 13 日取自http://law.moj.gov.tw/LawClass/LawContent.aspx?Pcode=L0020066。
6. Bismuth, C,Garnier, R,Dally, S,Fournier, PE,Scherrmann, JM(1982).Prognosis and treatment of paraquat poisoning a review of 28 cases.J Toxicol Clin Toxicol,19(5),461-474.
7. Bruce, SD,Hendrix, CC,Gentry, JH(2006).Palliative sedation in end of life care.Hosp Palliat Nurs,8(6),320-327.
8. Delirrad, M,Majidi, M,Boushehri, B(2015).Clinical features and prognosis of paraquat poisoning a review of 41 cases.Int J Clin Exp Med,15(8),8122-8828.
9. Devader, TE,Albrecht, R,Reiter, M(2012).Initiating palliative care in the emergency department.J Emerg Med,43(5),803-810.
10. Gawarammana, IB,Buckley, NA(2011).Medical management of paraquat ingestion.Br J Clin Pharmacol,72(5),745-757.
11. He, F,Xu, P,Zhang, J(2015).Efficacy and safety of pulse immunosuppressive therapy with glucocorticoid and cyclophosphamide in patients with paraquat poisoning a meta analysis.Int Immunopharmacol,27(1),1-7.
12. Kirk, TW,Mahon, MM(2010).National Hospice and Palliative Care Organization (NHPCO) position statement and commentary on the use of palliative sedation in imminently dying terminally ill patients.J Pain Symptom Manage,39(5),914-923.
13. Lanken, PN,Terry, PB,Delisser, HM(2008).An official American Thoracic Society clinical policy statement palliative care for patients with respiratory diseases and critical illnesses.Am J Respir Crit Care Med,177(8),912-927.
14. Lee, EY,Hwang, KY,Yang, JO,Hong, SY(2002).Predictors of survival after acute paraquat poisoning.Toxicol Ind Health,18(4),201-206.
15. Levy, MH,Cohen, SD(2005).Sedation for the relief of refractory symptoms in the imminently dying a fine intentional line.Semin Oncol,32(2),237-246.
16. Lin, C,Yen, TH,Juang, YY,Lin, JL,Lee, SH(2014).Psychiatric comorbidity and its impact on mortality in patients who attempted suicide by paraquat poisoning during 2000-2010.PLoS One,9(11),1-7.
17. Lin, WY,Chiu, TY,Hsu, HS(2009).Medical expenditure and family satisfaction between hospice and general care in terminal cancer patients in Taiwan.J Formos Med Assoc,108(10),794-802.
18. Lo, B,Rubenfeld, G(2005).Palliative sedation in dying patients we turn to it when everything else hasn't worked.JAMA,294(14),1810-1816.
19. Muller-Busch, HC,Andres, I,Jehser, T(2003).Sedation in palliative care a critical analysis of 7 years experience.BMC Palliat Care,2(1),1-9.
20. Myung, W,Lee, GH,Won, HH(2015).Paraquat prohibition and change in the suicide rate and methods in South Korea.PLoS One,10(6),1-10.
21. Prendergast, TJ(2001).Advance care planning pitfalls progress promise.Crit Care Med,29(2),34-39.
22. Quill, TE,Dress, R,Brock, DW(1997).The rule of double effect-a critique of its role in end-of-life decision-making.N Engl J Med,337,1761-1768.
23. Seok, SJ,Jeong, DS,Yang, JO,Lee, EY,Hong, SY(2009).Paraquat intoxication in subjects who attempt suicide why they chose paraquat.Korean J Intern Med,24(3),247-251.
24. Singer, PA,Lowy, FH(1992).Rationing patient preferences and cost of care at the end of life.Arch Intern Med,152(3),478-480.
25. Tan, JT,Letchuman Ramanathan, G,Choy, MP,Leela, R,Lim, BK(2013).Paraquat poisoning experience in hospital taiping (year 2008 - october 2011).Med J Malaysia,68(5),384-388.
26. Weerasuriya, D,Sheikh, S,Morgan, BW(2012).Do not resuscitate orders in fatal toxic exposures a poison center's review.West J Emerg Med,13(3),294-297.
27. Weng, CH,Hu, CC,Lin, JL,Lin-Tan, DT,Hsu, CW,Yen, TH(2013).Predictors of acute respiratory distress syndrome in patients with paraquat intoxication.PLoS One,8(12),1-8.
28. Wright, AA,Zhang, B,Ray, A(2008).Associations between end of life discussions patient mental health medical care near death and caregiver bereavement adjustment.JAMA,300(14),1665-1673.
29. Wu, WP,Lai, MN,Lin, CH,Li, YF,Lin, CY,Wu, MJ(2014).Addition of immunosuppressive treatment to hemoperfusion is associated with improved survival after paraquat poisoning a nationwide study.PLoS One,9(1),1-8.
30. 吳整昌(2009)。末期病人使用鎮靜治療的倫理議題。澄清醫護管理雜誌，5(2)，4-9。
31. 唐高駿,薛貴霞,蔡建和,陳秀丹(2005)。加護病房成本效益。中華民國急救加護醫學會雜誌，16(4)，139-145。
32. 高以信,陳世琦,江瑞坤,林小琪(2010)。有關癌末病人難治之症狀使用緩和鎮靜的議題。安寧療護雜誌，15(3)，319-330。
33. 莊艷妃,黃錦鳳,黃雅庭(2015)。比較北部與東部加護病房病患簽署不施行心肺復甦術同意書對臨終前醫療處置影響之差異。慈濟技術學院學報，24，1-18。
34. 許煌汶,林淑芬(2006)。安寧緩和鎮靜治療。安寧療護雜誌，11(4)，392-403。
35. 黃仁杰,蔡文正(2015)。台灣癌症病患於死亡前一年健保醫療費用支出之相關因素分析。澄清醫護管理雜誌，11(4)，10-19。
36. 黃馨葆,蔡兆勳,陳慶餘,邱泰源(2011)。生命末期照顧如何達到好的成本效益。安寧療護雜誌，16(2)，205-216。
37. 蔣文芳,詹正雄,陳金順(2013)。巴拉刈中毒及治療。腎臟與透析雜誌，25(3)，173-178。
38. 蔡文仁,洪培豪,潘吉豐,吳志仁,陳逸洲,陳漢湘(2013)。巴拉刈中毒的治療新進展。內科學誌，24(1)，48-63。

1. 蘇珉一,蕭嘉瑩,馬瑞菊,林佩璇(2017)。如何使病人得到善終－從加護病房談起。腫瘤護理雜誌，17(增訂刊)，39-50。
2. 蘇珉一,蕭嘉瑩,鄭婉如,黃琬庭,郭豐吉,梁婉真,馬瑞菊,林淑茹,林佩璇(2019)。內科加護病房急慢性透析病人簽署DNR同意書與醫療處置之經驗分析。安寧療護雜誌，23(2)，113-128。